> > > >
Contact:
sales@biotechnologyforums.com to feature here
Thread Rating:
  • 1 Vote(s) - 5 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Metreleptin wins FDA approval for lipodystrophy therapy
Offline
juraahgeh Offline
Banned
Posts: 4
Threads: 0
Likes Received: 0 in 0 posts
Likes Given: 0
Joined: Jun 2014
BioEXP: 0Bx
#2
06-06-2014, 06:11 PM
Myalept will be available only through a risk evaluation and mitigation strategy (REMS) program, which requires prescriber and pharmacy certification and special documentation.
Find Share
Like Post Reply
  


Messages In This Thread
RE: Metreleptin wins FDA approval for lipodystrophy therapy - by juraahgeh - 06-06-2014, 06:11 PM
Possibly Related Threads…
Thread
Author
  /  
Last Post
Biomarker for therapy resistance in HER2 positive breast cancer
mtwalsh01
Replies: 0
Views: 9,642
06-12-2014, 06:12 PM
Last Post: mtwalsh01
Future bright for faecal microbiota transplant therapy despite FDA regulation change
mtwalsh01
Replies: 0
Views: 8,505
05-16-2014, 08:52 PM
Last Post: mtwalsh01
Triple-negative breast cancer: trial to develop personalised therapy
mtwalsh01
Replies: 0
Views: 7,737
05-16-2014, 07:50 PM
Last Post: mtwalsh01
Possibilities for Amyotrophic Lateral Sclerosis therapy
mtwalsh01
Replies: 0
Views: 7,074
05-07-2014, 08:39 PM
Last Post: mtwalsh01
Unpicking two locks to selectively deliver cancer therapy
mtwalsh01
Replies: 0
Views: 6,898
05-07-2014, 07:44 PM
Last Post: mtwalsh01



Users browsing this thread:
1 Guest(s)

Metreleptin wins FDA approval for lipodystrophy therapy51